Autolus Therapeutics Presents Clinical Data Update at the 2024 Lymphoma, Leukemia & Myeloma Congress

4 weeks ago

• Findings suggest the potential for obe-cel treatment without the need for consolidative SCT • Obe-cel given as a sole treatment to patients with lower tumor burden at lymphodepletion was associated with better outcomes

Ticker	Sentiment	Impact
AUTL	Neutral	5 %